39
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T20626 |
Esomeprazole
|
Proton pump; Cysteine Protease | Membrane transporter/Ion channel; Proteases/Proteasome |
Esomeprazole 是奥美拉唑(omeprazole) 的S-异构体,抑制溶酶体半胱氨酸蛋白酶legumain,防止癌症转移。它是一种质子泵抑制剂(PPI)。 | |||
T1575 |
Nizatidine
Axid,Acinon,尼扎替丁,Zanizal |
AChE; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Nizatidine (Acinon) 是一种竞争性和可逆的组胺 H2 受体拮抗剂,具有抗酸活性,可用于胃溃疡的研究。 | |||
T2686L |
Esomeprazole Sodium
埃索美拉唑钠,(S)-Omeprazole sodium |
ATPase; Proton pump | Membrane transporter/Ion channel |
Esomeprazole Sodium ((S)-Omeprazole sodium) 是一种口服有效的活性质子泵抑制剂。Esomeprazole sodium 通过抑制胃壁细胞中的 H+, K+-ATPase 来降低酸分泌,在胃食管反流疾病中有研究价值。Esomeprazole 是一种外泌体抑制剂,通过抑制 V-H+-ATPases 来阻断外泌体的释放。 | |||
T0081 |
Lafutidine
拉呋替丁,FRG-8813 |
5-HT Receptor; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Lafutidine (FRG-8813) 是一种组胺受体 H2RA 拮抗剂,可抑制胃酸分泌,具有胃粘膜保护作用,可用于研究胃食管反流疾病。 | |||
T8388 |
Vonoprazan
TAK-438 (free base),沃诺拉赞 |
Proton pump | Membrane transporter/Ion channel |
Vonoprazan (TAK-438 (free base)) 是一种质子泵抑制剂,是口服活性钾竞争性酸阻断剂,有抗分泌作用。在 pH 为 6.5 时,它抑制猪胃微粒体中的 H+,K+-ATPase 酶活性,IC50值为 19 nM。它可用于研究胃酸相关疾病。 | |||
T21254 |
Vonoprazan Fumarate
TAK-438,TAK 438,Vonoprazan Fumurate,TAK438,富马酸沃诺拉赞 |
Proton pump | Membrane transporter/Ion channel |
Vonoprazan Fumarate (TAK438) 是质子泵的有效抑制剂,是口服有效的高效钾竞争性酸阻断剂,具有抗分泌活性。在 pH 为 6.5 时,它抑制猪胃微粒体中的 H+,K+-ATPase 酶活性,IC50为 19 nM。它被开发用于研究酸相关疾病,如消化性溃疡和胃食管反流病。 | |||
T1651 |
Rabeprazole sodium
Dexrabeprazole Sodium,LY307640 sodium,Habeprazole Sodium,雷贝拉唑钠,Rebeprazole sodium,Aciphex Sodium |
Apoptosis; Proton pump | Apoptosis; Membrane transporter/Ion channel |
Rabeprazole sodium (Habeprazole Sodium) 是一种质子泵抑制剂,不可逆地抑制胃 H+/K+-ATPase,可研究胃溃疡和胃食管反流。它诱导细胞凋亡,也抑制尿苷核苷核糖水解酶 ,IC50为 0.3 μM。 | |||
T14389 |
AZD 9272
|
GluR | Neuroscience |
AZD 9272 是一种脑渗透性的mGluR5 拮抗剂,可用于研究胃食管反流。 | |||
T2093 |
PF 03716556
PF-3716556 |
ATPase | Membrane transporter/Ion channel |
PF 03716556 (PF-3716556) 是一种有效且特异性的 P-CAB(钾竞争性酸阻滞剂),用于治疗胃食管反流病。 | |||
T6928 |
Pantoprazole
SKF96022,泮托拉唑,BY1023 |
Apoptosis; Proton pump; Autophagy | Apoptosis; Autophagy; Membrane transporter/Ion channel |
Pantoprazole (BY1023) 是一种质子泵抑制剂,用于短期治疗由胃食管反流病引起的食管糜烂和溃疡。它联合阿霉素可显著增加肿瘤生长延迟。它是一种取代的苯并咪唑,是H+/K+-ATPase 抑制剂,可改善 pH 值稳定性,具有抗分泌和抗溃疡的作用。 | |||
T1756L |
Ilaprazole
IY81149,艾普拉唑,IY 81149,IY-81149 |
Proton pump; TOPK | MAPK; Membrane transporter/Ion channel |
Ilaprazole (IY-81149) 是一种具有口服活性质子泵抑制剂,以剂量依赖性方式不可逆地抑制H+/K+-ATPase,在兔壁细胞制剂中的IC50为 6 μM。它也是一种有效的T 细胞起源蛋白激酶(TOPK)抑制剂,用于胃溃疡的研究。 | |||
T0161 |
Pantoprazole Sodium Hydrate
SKF96022 sodium hydrate,泮托拉唑钠水合物,BY1023 (sodium hydrate),SKF96022 (sodium hydrate) |
Apoptosis; Potassium Channel; Proton pump; Autophagy | Apoptosis; Autophagy; Membrane transporter/Ion channel |
Pantoprazole Sodium Hydrate (BY1023 (sodium hydrate)) 是一种具有口服活性的质子泵抑制剂。它是取代的苯并咪唑,是H+/K+-ATPase 抑制剂。它可改善 pH 值稳定性,具有抗分泌和抗溃疡的作用。它联合阿霉素可显著增加肿瘤生长延迟。 | |||
T69984 |
Ticalopride
|
5-HT Receptor | GPCR/G Protein; Neuroscience |
Ticalopride是一种5-HT3 receptor激动剂,可用于治疗消化系统疾病、口颌疾病、耳鼻咽喉疾病,可用于研究神经性贪食症、胃食管反流和肠易激综合征。 | |||
T10221 |
Abeprazan hydrochloride
DWP14012 hydrochloride,Fexuprazan hydrochloride |
Proton pump | Membrane transporter/Ion channel |
Abeprazan hydrochloride (Fexuprazan hydrochloride) 是一种有效的、可逆的、具有口服活性的potassium-competitive acid 阻滞剂,通过竞争性的与钾离子结合抑制 H+,K+- ATPase,而无需酸激活。Abeprazan hydrochloride 是一种质子泵抑制剂(PPI),通过减少胃酸的产生而起作用,可用于治疗胃酸相关疾病,如胃食管反流病(GERD)和消化性溃疡。 | |||
T8386 |
Esomeprazole Magnesium trihydrate
埃索美拉唑镁三水合物,埃索美拉唑镁(三水),(S)-Omeprazole magnesium trihydrate |
Proton pump | Membrane transporter/Ion channel |
Esomeprazole Magnesium trihydrate ((S)-Omeprazole magnesium trihydrate) 是一种口服有效的H+, K+-ATPase 抑制剂,在上消化道疾病和胃食管反流疾病的研究中具有价值。它是一种外泌体抑制剂,通过抑制 V-H+-ATPases 来阻断外泌体的释放。 | |||
T4616 |
Metoclopramide
甲氧氯普胺,胃复安,5-Chloro-2-methoxyprocainamide |
Dopamine Receptor; 5-HT Receptor | GPCR/G Protein; Neuroscience |
Metoclopramide (5-Chloro-2-methoxyprocainamide) 是5-HT3和多巴胺D2受体拮抗剂,IC50值分别为 308 和 483 nM,可用于恶心呕吐、胃食管反流和胃轻瘫的研究。 | |||
T33402 |
Mitemcinal fumarate
GM 611,Kita-ku Tokyo,GM-611,Kita-ku Toyko,GM611 |
||
Mitemcinal fumarate is a erythromycin derivative that is used to treat gastroesophageal reflux disease. | |||
T26727 |
Azeloprazole
E-3710,Z215,E3710,Z 215,E 3710,Z-215 |
||
Azeloprazole, a proton pump inhibitor, is used potentially for the treatment of gastroesophageal reflux disease (GERD). | |||
T70127 | Famotine | ||
Famotine is a histamine H2 receptor antagonist that inhibits stomach acid production. It is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease. | |||
T71049 | Famotidine disulfide | ||
Famotidine disulfide is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease. | |||
T70090 |
Nizatidine amide
|
||
Nizatidine amide is a histamine H2 receptor antagonist that inhibits stomach acid production. It is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease. | |||
T1552L |
Itopride free base
HSR803,HSR-803,Itopride hydrochloride,HSR 803 |
||
Itopride HCl is an AChE inhibitor and dopamine D2 receptor antagonist. It inhibits lower esophageal sphincter relaxation. It also used to treat functional dyspepsia and gastroesophageal reflux disease | |||
T16737 |
Revexepride
|
Others | Others |
Revexepride is a highly selective agonist of the 5-HT4 receptor and a potential inducer of CYP3A4 enzyme. Revexepride is used for the treatment of gastroesophageal reflux disease. | |||
T16683 |
Pumosetrag Hydrochloride
MKC-733,DDP-733 |
5-HT Receptor | GPCR/G Protein; Neuroscience |
Pumosetrag Hydrochloride is an orally available 5-HT3 partial agonist. It is developed for the treatment of irritable bowel syndrome and gastroesophageal reflux disease. | |||
T71485 |
Famotidine propionic acid
|
||
Famotidine propionic acid is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease. | |||
T68725 |
Famotidine propanamide
|
||
Famotidine propanamide is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease. | |||
T71509 |
Famotidine sulfamoyl propanamide
|
||
Famotidine sulfamoyl propanamide is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease. | |||
T27640 |
Itriglumide
CR-2945,CR2945,CR 2945 |
||
Itriglumide, a CCK2 receptor antagonist, is used potentially for the treatment of peptic ulcers, dyspepsia, and gastroesophageal reflux disease (GERD). | |||
T61740 |
Esomeprazole hemistrontium
|
||
Esomeprazole hemistrontium, also known as (S)-Omeprazole, is a potent and orally active proton pump inhibitor that effectively reduces acid secretion by inhibiting the H+, K+-ATPase in gastric parietal cells. This compound exhibits promising potential for research in symptomatic gastroesophageal reflux disease [1] [2] [3]. | |||
T31743 |
Famotine hydrochloride
Famotine HCl,UK-2054 |
||
Famotine Hydrochloride is a histamine H2 receptor antagonist that suppresses acid production in the stomach and commonly treats peptic ulcer disease and gastroesophageal reflux disease. | |||
T61467 |
Esomeprazole magnesium salt
|
||
Esomeprazole magnesium salt is a potent and orally active proton pump inhibitor that effectively reduces acid secretion in gastric parietal cells by inhibiting the H+, K+-ATPase. This compound has shown promise for the research and treatment of symptomatic gastroesophageal reflux disease [1][2][3]. | |||
T71980 |
Omeprazole acid
|
||
Omeprazole acid is a medication used in the treatment of gastroesophageal reflux disease, peptic ulcer disease, and Zollinger–Ellison syndrome. It is also used to prevent upper gastrointestinal bleeding in people who are at high risk. Omeprazole is a proton pump inhibitor and as such blocks the release of stomach acid. | |||
T19929 |
Ranitidine-S-oxide
|
||
Ranitidine-S-oxide is a metabolite of Ranitidine. It is commonly used in the treatment of peptic ulcer disease, Zollinger–Ellison syndrome,and gastroesophageal reflux disease. | |||
T77180 | Retifanlimab | ||
Retifanlimab为一种抗程序性细胞死亡蛋白1(anti-PD-1)单克隆抗体(mAb),主要用于胃食道腺癌(GEA)的研究。 | |||
T30118 |
Arbaclofen placarbil
XP 19986,XP19986,XP-19986 |
||
Arbaclofen placarbil( XP19986) is a GABA(B) receptor agonist.Arbaclofen Placarbil is a novel R-baclofen prodrug with improved absorption, distribution, metabolism, and elimination properties compared to R-baclofen. And it can reduce postprandial reflux in | |||
T61667 |
Esomeprazole potassium salt
|
||
Esomeprazole potassium salt ((S)-Omeprazole potassium salt) is an effective and orally active proton pump inhibitor that works by inhibiting the H+, K+-ATPase enzyme in the gastric parietal cells, leading to a reduction in acid secretion. It is a promising compound for investigating symptomatic gastroesophageal reflux disease [1] [2] [3]. | |||
T81594 |
Osemitamab
TST001 |
||
Osemitamab是一种针对人类claudin-18.2的IgG1单克隆抗体。它由来自人鼠嵌合体TST001的γ-1链与κ链通过二硫键连接而成的二聚体(ACI)构成。该化合物与Capecitabine和Oxaliplatin联合应用,适用于胃(G)及胃食管结合部(GEJ)癌症的研究。 | |||
T61643 | Vonoprazan hydrochloride | ||
Vonoprazan hydrochloride 是一种高效且具口服活性的质子泵抑制剂 (PPI) 和钾竞争性酸阻断剂 (potassium-competitive acid blocker, P-CAB),展示出优秀的抗分泌活性。在 pH 为 6.5 的条件下,该化合物可抑制猪胃微粒体内 H+,K+-ATPase 的酶活性,呈现出 19 nM 的 IC50 值。Vonoprazan hydrochloride 主要应用于胃酸相关疾病的研究,包括胃食管反流病和消化性溃疡,并可用于根除幽门螺杆菌。 | |||
T70070 |
Cisapride tartrate
|
||
Cisapride tartrate is chemically related to metoclopramide, but unlike metoclopramide, it does not cross the blood-brain barrier or have antidopaminergic effects. Cisapride is a serotonin-4 (5-HT4) receptor agonist. Cisapride was indicated for the symptomatic treatment of adult patients with nocturnal heartburn due to gastroesophageal reflux disease. The Food and Drug Administration (FDA) in America stopped the marketing of cisapride as of 14th July 2000. They had received at least 341 reports o... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21651 |
Lansoprazole sodium
兰索拉唑钠,Lansoprazole (sodium), AG-1749 sodium |
Proton pump; Phospholipase; Antibacterial | Membrane transporter/Ion channel; Metabolism; Microbiology/Virology |
Lansoprazole sodium (Lansoprazole (sodium)) 是一种质子泵抑制剂,是中性鞘磷脂酶的外泌体抑制剂,能抑制胃酸生成。 |